References
1)
Hilpert,
H., et al., 2013. b-Secretase (BACE1) Inhibitors with High
in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s Disease. J. Med. Chem 56: 3890-3995.
2) Venugopal, C., et al., 2008. Beta-secretase: Structure, Function, and Evolution. CNS & neurological disorders drug targets 7: 278–294.
3) Kuglstatter, A., Stihle, M. PDB X-ray Structure Validation Report. 2013.
4)
Protein
identification and analysis tools on the ExPASy server. Gasteiger, E. et. al.
In J. M. Walker (Ed.) The proteomics
protocols handbook. Totowa, New Jersey: Humana Press Inc. 2005.
5)
Gueto-Tettay,
et al., 2016. A molecular dynamics study of the BACE1 conformational change
from Apo to closed form induced by hydroxyethylamine derived compounds. Journal of Molecular Graphics and Modelling
70:181–195.
6)
Shimizu,
Hideaki, 2008. Crystal Structure of an Active Form of BACE1, an Enzyme
Responsible for Amyloid Protein Production. Molecular
and Cellular Biology 28:
3663–3671.
7) Patel, S., et al., 2004. Apo
and Inhibitor Complex Structures of BACE (b-Secretase). J. Mol. Biol. 343:
407-416.
8) Manoharan, P., et al., 2017.
Computational analysis of BACE1-ligand complex crystal structures and linear
discriminant analysis for identification of BACE1 inhibitors with anti P-
glycoprotein binding property. Journal of
Biomolecular Structure and Dynamics 0:
1-15.
9) Altschul, S., et al., 1997. Gapped BLAST
and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Research 25: 3389-3402.
10) Basic Local
Alignment Search Tool. National Center for Biotechnology Information. 2012.
http://www.ncbi.nlm.nih.gov/blast/Blast.cgi
11) Dali server:
conservation mapping in 3D. Nucl. Acids Res. 38,
W545-549. Holm L, Rosenström, P. 2010.
12) Annaert, W., De Strooper, B.,
2002. A Cell Biological Perspective on Alzheimer’s Disease. Annu. Rev. Cell Dev. Biol. 18: 25-51.